Marshall of Cambridge announces the formation of Martlet, a corporate angel initiative. Peter Cowley has been appointed as Investment Director. Each year, Martlet will invest in several early-stage companies with high growth potential, as co-investees with other angels and seed funds.
Martlet – Marshall of Cambridge accelerates corporate angel investment
Marshall of Cambridge announces the formation of Martlet, a corporate angel initiative. After several successful investments in start-up companies, Martlet has been formed to expand on that opportunity. Marshall has appointed Peter Cowley, a seasoned mentor/angel investor to head up Martlet as investment director. Each year, Martlet will invest in several early-stage companies with high growth potential, as co-investees with other angels and seed funds.
Investments will be made primarily in companies within Greater Cambridge and East Anglia at an early stage, with sums of £25,000 to £100,000 being invested in each selected opportunity. Martlet will not be concentrating on specific market sectors, and will invest in a variety of entrepreneurial people and teams with an idea, an identified market, a recognised monetisation opportunity and excellent growth potential.
Robert Marshall, Chief Operating Officer of Marshall, said: “We are very excited to be able to support some of the many excellent local start-ups. We are very pleased that Peter Cowley will head up the new division. We anticipate contributing further to the growth of the UK economy”
Peter Cowley, Martlet Investment Director, said: “I have been involved in my own Cambridge-based start-up companies and mentoring/investing in start-ups for many years. My connections within the angel community will provide excellent potential deal leads, and we are keen to hear from other entrepreneurs that are looking for investment.”
Martlet has already identified several investment opportunities and welcomes new introductions from local entrepreneurs who are seeking early stage funding.
Marshall of Cambridge
Founded in 1909 with little capital as a chauffeur drive company in Cambridge, Marshall moved into the retail motor business in 1910 and entered the aviation business in 1929. With all its growth funded by ploughed-back profits, the Marshall Group remains a privately owned family Company, with a turnover of around £1bn per annum. The Group of Companies is chaired by the third generation of the Marshall family, and employs members of the fourth generation. The Group currently employs just over 4,500 people working in the fields of aerospace engineering; design and manufacture of specialist vehicle applications, military mobility shelters and hospital surgical units; motor vehicle sales and after sales support; refrigerated transport sales and support; and property ownership and management.
Marshall is the second largest privately owned Motor Group in the UK and was the recipient of 10 Major National Awards in 2010. Since 2009, it has added 27 businesses to the Group, which amounted to 9 new motor brands. Marshall Aerospace, which enjoys an international reputation for the quality of its work, is the largest privately owned Aviation Maintenance, Repair and Overhaul Business in the UK, with extensive Design facilities; this business looks after Hercules aircraft of the RAF, and those of numerous other nations. Marshall Land Systems is also a “world class” company specialising in high technology mobility solutions. See www.marshallgroup.co.uk
Peter Cowley has a Cambridge University degree in Engineering and Computing Science, lived in Bavaria for five years and owns technology and construction businesses. Peter has personally been investing in high growth start-ups for many years and is a board member of the Cambridge Angels. He has run the Computing Laboratory Ring mentoring scheme for eight years and is chair of the ideaSpace supporter group. He has been treasurer and chair of several charities in the advice, healthcare and education sectors. See www.linkedin.com/in/plcowley
Martlet is a Cambridge-based investor in early-stage IP rich deep technology and life science start-ups